Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: Relationship to maximal airway narrowing

Annals of Allergy, Asthma and Immunology

Volumn 80, Issue 2, 1998, Pages 151-158

  Prieto, L ^a   Gutierrez V ^a   Morales, C ^a   Perpinan J ^a   Inchaurraga, I ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHACHOLINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHOSPASM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL;

EID: 2642646264     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62948-1     Document Type: Article

References (41)

1. Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981;68: 347-55.
2. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma: an ultrastructural quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-53.
3. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
4. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87: 893-910.
5. Moreno RH, Hogg JC, Paré PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986;133:1171-80.
6. Woolcock AJ, Salome CM, Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis 1984; 130:71-5.
7. James A, Lougheed D, Pearce-Pinto G, et al. Maximal airway narrowing in a general population. Am Rev Respir Dis 1992;146:895-9.
8. Townley RG, Ryo UY, Kolotkin BM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975;56:429-42.
9. De Pee S, Timmers MC, Hermans J, et al. Comparison of maximal airway narrowing to methacholine between children and adults. Eur Respir J 1991; 4:421-8.
10. Sterk PJ, Daniel EF, Zamel N, Hargreave FE. Limited bronchoconstriction to methacholine using partial flow-volume curves in nonasthmatic subjects. Am Rev Respir Dis 1985; 132:272-7.
11. Hetzel MR, Clark JJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980;35:732-8.
12. Higgins BG, Britton JR, Chinn S, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989;140: 1368-72.
13. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991;143:323-30.
14. Frischer T, Meinert R, Urbanek R, Kuehr J. Variability of peak expiratory flow rate in children: short and long term reproducibility. Thorax 1995; 50:35-9.
15. Boezen HM, Schouten JP, Postma DS, Rijcken B. Relation between respiratory symptoms, pulmonary function and peak flow variability in adults. Thorax 1995;50:121-6.
16. Brand PLP, Postma DS, Kerstjens HAM, Koëter GH, and The Dutch CNSLD Study Group. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. Am Rev Respir Dis 1991;143:916-21.
17. Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway caliber. Thorax 1982;37:423-9.
18. 1 and peak expiratory flow rates among normal and asthmatic subjects. Thorax 1994;49: 775-80.
19. Valleta EA, Comis A, Del Col G, et al. Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposure. Allergy 1995;50:366-9.
20. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy Clin Immunol 1985;75: 573-7.
21. Gibson PG, Mattoli S, Sears MR, et al. Increased peak flow variability in children with asymptomatic hyperresponsiveness. Eur Respir J 1995;8:1731-5.
22. Prieto L, Gutiérrez V, Bertó JM, et al. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis. Ann Allergy Asthma Immunol 1995;75:273-9.
23. National Heart, Lung, and Blood Institute, National Institutes of Health. International consensus report on diagnosis and treatment of asthma. Clin Exp Allergy 1992;22(Suppl 1):1-72.
24. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987;136: 1285-98.
25. Quanjer PhH, ed. Standardized long function testing. Bull Eur Physiopathol Respir 1983;19(Suppl 5):1-95.
26. Cockcroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977;7: 235-43.
27. 20 and maximal degree of airway narrowing to methacholine after pollen season in pollen sensitive asthmatic patients. Clin Exp Allergy 1993;23:172-8.
28. Prieto L, Marín J. Methacholine inhalation challenge. Practical consequences of using duplicate spirograms after each concentration. Ann Allergy 1993;70:487-90.
29. Prieto JL, Gutiérrez V, Bertó JM, Camps B. Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis. Clin Exp Allergy 1996;26:61-7.
30. Sterk PJ, Timmers MC, Dijkman JH. Maximal narrowing in humans in vivo. Histamine compared with methacholine. Am Rev Respir Dis 1986;134:714-8.
31. Prieto L, López M, Bertó JM, Peris A. Modification of concentration-response curves to inhaled methacholine after the pollen season in subjects with pollen-induced rhinitis. Thorax 1994; 49:711-3.
32. Prieto L, Bertó JM, Gutiérrez V, Tornero C. Effect of inhaled budesonide on seasonal changes in sensitivity and maximal response to methacholine in pollen-sensitive asthmatic subjects. Eur Respir J 1994;7:1845-51.
33. Brusasco V, Pellegrino R, Violante B, Crimi E. Relationship between quasistatic pulmonary hysteresis and maximal airway narrowing in humans. J Appl Physiol 1992;72:2075-80.
34. Pellegrino R, Violante B, Brusasco V. Maximal bronchoconstriction in humans. Relationship to deep inhalation and airway sensitivity. Am J Respir Crit Care Med 1996;153:115-21.
35. Bradley BL, Azzawi M, Irani AMA, et al. Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 1991;88:661-74.
36. Pin Y, Radford S, Kolendowicz R, et al. Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J 1993;6:1249-56.
37. Aubier M, Levy J, Clerici Ch, et al. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992;146:122-8.
38. Hopp RJ, Townley RG, Biven RF, et al. The presence of airway reactivity before the development of asthma. Am Rev Respir Dis 1990;141:2-8.
39. Wiggs BR, Bosken C, Paré PD, et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.
40. Hagy GW, Settipane GA. Risk factors for developing asthma and allergic rhinitis. A 7-year follow-up study of college students. J Allergy Clin Immunol 1976;58:330-6.
41. Prieto L, Bertó JM, Gutiérrez V. Airway responsiveness to methacholine and risk of asthma in patients with allergic rhinitis. Ann Allergy 1994;72: 534-9.